Search for the latest updates on Argo
News
Biocancell to raise NIS 29m in rights issue Globes Online - 47 minutes
Len Blavatik's Clal Biotechnology will buy at least half the shares.
Manage alerts · Unsubscribe · Privacy Policy
Tip: To search for an exact phrase, put quotation marks around two or more words.
| You received this email because you subscribed to Yahoo! Alerts. |
No comments:
Post a Comment